Trials / Completed
CompletedNCT00204620
Bendamustin Hydrochloride in Patients With Soft Tissue Sarcoma (STS)
Multicenter Phase II Study With Bendamustin for Patients With Refractory Soft Tissue Sarcoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 28 (planned)
- Sponsor
- University Hospital Tuebingen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aims of this trial are to evaluate the efficacy of bendamustin in patients with metastatic soft tissue sarcoma who have progressed after or during an anthracycline-baesd chemotherapy and to assess the treatment of toxicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bendamustin |
Timeline
- Start date
- 2002-03-01
- Completion
- 2006-12-01
- First posted
- 2005-09-20
- Last updated
- 2007-04-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00204620. Inclusion in this directory is not an endorsement.